Trial intelligence / Profile preview

Testosterone cypionate in athletes stratified by UGT2B17 polymorphism

2013-005135-24Phase 4Completed

Sponsor
Cristina Fernandez Pérez
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of testosterone cypionate in None (2 arms), sponsored by Cristina Fernandez Pérez. Primary endpoint: Urinary steroid concentrations. Started Jan 2014; status: completed.

02

Drugs

testosterone cypionate

Beyond the preview

Go deeper on 2013-005135-24.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-005135-24.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call